| Source: |
| Type: |
miR-194 is a small, non-coding RNA enriched in epithelial tissues (notably liver, intestine, and kidney). Its physiologic role is to reinforce epithelial differentiation by repressing transcripts that drive motility, EMT, and stemness.
-Commonly DOWNREGULATED in many solid tumors during progression.
-Loss of miR-194 facilitates EMT, invasion, metastasis, and therapy resistance.
miR-194 is a tumor-suppressive microRNA whose loss marks transition toward EMT, invasion, and metastatic competence. As a biomarker, it is best used to interpret tumor state and risk—especially differentiation versus plasticity—rather than to diagnose cancer or choose a specific therapy.br |
| 7749- | ISL, | Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1 |
| - | in-vitro, | GBM, | U87MG |
| 4931- | PEITC, | Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194 |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1415 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid